Likewise, we believed that knockdown of GLO1 would lead not only to kidney disease as we have previously shown (Giacco et al. 2014) but also increase atherosclerosis in nondiabetic Apoe−/− mice. This evidence concerns the gene GLO1 and kidney disorder.